Live Chat

Los Contratos por diferencia («CFD») son instrumentos complejos que comportan un riesgo elevado de pérdidas rápidas debido al apalancamiento. El 74% de las cuentas de inversores particulares pierde dinero al operar CFD con este proveedor. Debe considerar si comprende el funcionamiento de los CFD y si puede permitirse asumir un riesgo elevado de perder su dinero.

Close

Opere Bayer BAYGn

Vender
 Comprar

Bayer gráfico en tiempo real

5m 15m 30m 1h 4h 1d 1w

Fundamentales del instrumento

Weekly Search
Weekly
Daily
Fecha Cerrar Cambio Cambio del % Apertura Alto Bajo

Últimas noticias

US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Adelanto semanal: Tasas en EE. UU. e inflación en Europa determinarán el curso del mercado

Forex Índices
Dyogenes Diniz 2024 Dec 05, 16:00

Adelanto semanal: La inflación y las tasas de interés sacudirán los mercados esta semana

Forex Índices
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Adelanto semanal:  El empleo en EE. UU. marcará probablemente el sentimiento de mercado esta semana.

Forex Índices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Adelanto semanal:  Inflación de la Eurozona podría confirmar el recorte del BCE en diciembre

Forex Índices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Adelanto semanal: El rally tecnológico dependerá de los resultados de Nvidia

Forex Índices
Markets.com Support Team 2024 Nov 07, 16:00

Adelanto semanal: «Trump Trade», datos de inflación, resultados de Disney

Forex Índices
US Election 2024, Harris vs Trump
Markets.com Support Team 2024 Oct 31, 16:00

Adelanto semanal: Trump vs Harris - Enfrentamiento electoral en EE. UU.

Forex Índices
Big Tech, Apple, Meta, Microsoft, Amazon & Alphabet
Markets.com Support Team 2024 Oct 24, 16:00

Adelanto semanal:  Apple encabeza las ganancias de las grandes tecnológicas, presupuesto del Reino Unido y nóminas no agrícolas

Forex Índices

Información

Spread

0.13

Spread (%)

0.6757 %

Apalancamiento

1:5

Interés a un día (Compra)

-0.0556 %

Interés a un día (Venta)

-0.0333 %

Divisa

EUR

Horarios de los mercados

Markets closed

Miércoles

08:02 - 11:59

Lunes

08:02-11:59

Lunes

12:04-16:29

Martes

08:02-11:59

Martes

12:04-16:29

Jueves

08:02-11:59

Jueves

12:04-16:29

Viernes

08:02-11:59

Viernes

12:04-16:29

Análisis y estadísticas

Apertura

---

Cierre anterior

---

Máximo/mínimo de 52 semanas

--- – ---

Capitalización de mercado

19155302400

Acciones en circulación

982424000

Fecha de ganancias (próxima)

2018-06-06

Rentabilidad por div. 

Fecha exdividendo

2024-04-29

Tasa de dividendo anual anticipado

0.11

Rendimiento de dividendo anual anticipado

0.0056

GPA

-0.89

Conoce más sobre este instrumento

Bayer Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Instrumentos relacionados

Activo
Vender
Comprar
Cambio del %

Opere ahora

Opere ahora

Opere ahora

Opere ahora
Instrumentos relacionados
Trustpilot
Live Chat